Company Profile

Moss Genomics Inc. is a Canada-based biotechnology company utilizing artificial intelligence, genomic, micro-biomes, and a diverse array of health data to develop health solutions. The Company offers personalized health, anti-aging and wellness offerings. The company leverages blockchain technology to enhance security and user control over genomic information. Along with its genomics-focused products. The Company operates in single segment.

Employees

Sector

Biotechnology & Medical Research

More about the company

Market Closed - OTC Markets Other stock markets 09:30:11 2026-06-18 EDT			5-day change	1st Jan Change
0.0260 ^USD	+85.71%		-.--%	-66.19%

11-10	Moss Genomics Inc. announced that it has received CAD 0.1 million in funding	CI
25-06-17	Genomesio Limited announced that it expects to receive CAD 0.2 million in funding from Moss Genomics Inc.	CI

11-10	Moss Genomics Inc. announced that it has received CAD 0.1 million in funding	CI
25-06-17	Genomesio Limited announced that it expects to receive CAD 0.2 million in funding from Moss Genomics Inc.	CI
25-04-28	Moss Genomics Inc. Launches "Perennial" Genomics Platform	CI
25-04-27	Moss Genomics Inc. announced that it expects to receive CAD 0.455 million in funding	CI
25-02-26	Moss Genomics Names Michal Goldstein as Fractional CFO	MT
25-02-26	Moss Genomics Inc. Appoints Michal Goldstein as its Fractional Chief Financial Officer	CI
25-02-26	Moss Genomics Inc. Appoints Joseph De Pinto to Its Board of Directors	CI
25-02-02	Moss Genomics Inc. announced that it expects to receive CAD 0.36 million in funding	CI
25-01-30	Moss Genomics Inc. announced that it has received CAD 0.25 million in funding	CI
24-12-24	Moss Genomics Inc. Announces CEO Changes	CI
24-12-24	Moss Genomics Inc. Announces Board Changes	CI
24-12-23	Moss Genomics Inc. announced that it expects to receive CAD 0.25 million in funding	CI
24-07-18	Moss Genomics Inc. Announces Board Changes	CI

01-05	Moss Genomics Reports Bitcoin Cash (BCH) Mining Activity	NE
11-12	Moss Genomics Announces Closing of Financing Round	NE
25-07-10	Moss Genomics Advances Blockchain Integration Strategy	NE
25-06-19	Moss Genomics Announces Strategic Investment in Genomes.io	NE
25-04-28	Moss Genomics Launches "Perennial" Genomics Platform, Closes on 130 ETH	NE

1 day	+85.71%
1 month	+10.64%
3 months	+15.56%
6 months	-66.19%
Current year	-66.19%

Moss Genomics Inc. Stock OTC Markets

Stocks

MSSGF

CA61965T1012

Biotechnology & Medical Research

Chart: Moss Genomics Inc.

Latest news : Moss Genomics Inc.

Press Releases: Moss Genomics Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Moss Genomics Inc.

Other Biotechnology & Medical Research

Company Profile

1 month	0.03	0.03
Current year	0.01	0.1
1 year	0.01	0.25
3 years	0.01	0.4
5 years	0.01	0.4
10 years	0.01	0.4

Manager	Title	Age	Since
Chen Qui Liu CEO	Chief Executive Officer	39	2024-12-22
Mickey Goldstein DFI	Director of Finance/CFO	45	2025-02-23
Aruna Rajan PRN	Corporate Officer/Principal	-	-

Director	Title	Age	Since
Chen Qui Liu BRD	Director/Board Member	39	2024-12-22
Joseph De Pinto BRD	Director/Board Member	37	2025-02-10
Hunter Jordan BRD	Director/Board Member	39	2025-01-30

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MOSS GENOMICS INC.	+85.71%	-.--%	-	-	1.56M
LONZA GROUP AG	0.00%	+5.65%	+1.44%	+6.69%	49.15B
REVOLUTION MEDICINES, INC.	+0.92%	+6.21%	+408.85%	+607.44%	40.23B
IQVIA HOLDINGS INC.	+1.89%	+11.06%	+25.75%	-7.89%	34.55B
BEONE MEDICINES AG	+2.38%	+8.10%	+21.83%	+66.94%	33.09B
CELLTRION, INC.	+1.20%	+2.02%	+9.79%	+32.43%	25.19B
ASCENDIS PHARMA A/S	+2.51%	+4.94%	-	-	17.05B
MEDPACE HOLDINGS, INC.	+2.58%	+7.24%	+71.03%	+132.17%	15.92B
EUROFINS SCIENTIFIC SE	-0.35%	-0.09%	+12.91%	+18.30%	13.83B
ICON PUBLIC LIMITED COMPANY	-1.14%	+7.52%	+14.75%	-30.83%	13.26B
Average	+9.57%	+6.43%	+70.79%	+103.16%	26.92B
Weighted average by Cap.	+1.14%	+6.73%	+88.28%	+130.87%